NDC1 promotes hepatocellular carcinoma tumorigenesis by targeting BCAP31 to activate PI3K/AKT signaling

  • Ya ping Liu
  • , Gang Guo
  • , Mudan Ren
  • , Ya rui Li
  • , Dan Guo
  • , Jun jun She
  • , Shui xiang He

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Hepatocellular carcinoma (HCC) is among the world's worst malignancies. Nuclear division cycle 1 (NDC1) is an essential membrane-integral nucleoporin, found in this study to be significantly increased in primary HCC. A multivariate analysis revealed that higher NDC1 expression was linked to worse outcome in HCC patients. Mouse xenograft tumors overexpressing NDC1 grew rapidly, and HCC cells overexpressing NDC1 showed enhanced proliferation, invasion, and migration in vitro. In contrast, knocking down NDC1 had the opposite effects in vitro. Furthermore, co-immunoprecipitation and liquid chromatograph mass spectrometer analyses revealed that NDC1 activated PI3K/AKT signaling by interacting with BCAP31. In summary, NDC1 and BCAP31 cooperate to promote the PI3K/AKT pathway, which is essential for HCC carcinogenesis. This suggests that NDC1 is predictive of prognosis in HCC.

Original languageEnglish
Article numbere23647
JournalJournal of Biochemical and Molecular Toxicology
Volume38
Issue number2
DOIs
StatePublished - Feb 2024
Externally publishedYes

Keywords

  • BCAP31
  • NDC1
  • PI3K/AKT signaling
  • hepatocellular carcinoma

Fingerprint

Dive into the research topics of 'NDC1 promotes hepatocellular carcinoma tumorigenesis by targeting BCAP31 to activate PI3K/AKT signaling'. Together they form a unique fingerprint.

Cite this